Thiadiazolediamine derivative with histamine H-2 receptor inhibiting properties
US4529731A · kind A · utility
0Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1983 |
| Grant date | Jul 16, 1985 |
| Priority date | — |
| Expiry date | Sep 22, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D285/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
N-[2-(dimethylamino)ethyl]-N'-[3-[3-[(1-piperidinyl)methyl]phenoxy]-propyl] -1,2,5-thiadiazole-3,4-diamine, 1-oxide is a long acting histamine H-2 receptor antagonist. The compound inhibits gastric acid secretion, and prevents and alleviates ulcers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.